Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
04 October 2019 | Story Valentino Ndaba | Photo Barend Nagel
BCom degree
Prospective students are invited to apply for the new BCom Business and Financial Analytics 2020 intake.
A new qualification has recently been added to the University of the Free State (UFS) curriculum and 30 prospective students still have the opportunity to form part of the BCom with specialisation in Business and Financial Analytics intake for 2020. The deadline for applications has been extended to 31 October 2019. 

Committed to the 4th industrial revolution

This flagship degree has been designed for the 4th Industrial Revolution as it integrates quantitative analysis, computer science, statistics and business. This new qualification will equip graduates to become high-functioning executives in the modern global business world. 

“The Faculty of Economic and Management Sciences identified the need for a BCom programme incorporating some of these skills in a more deliberate way, in order to prepare our graduates for a changing job market,” says Lizette Pretorius, Faculty Manager.

On par with global standards

International institutions such as Harvard Business School, Carnegie Mellon University, Duke University, and Columbia University have led the way by adopting this cohesive approach to business studies. These universities form part of a listing of the 25 top US schools offering Master’s in Business Analytics programmes. 

The UFS is following in these leading institutions as part of its Integrated Transformation Plan (ITP) to produce globally competitive graduates. According to the ITP: “The future state of engaged scholarship will be an important anchor in maintaining the relevance of the academic syllabus, and linking real local needs to the global knowledge project.”

 Click here to complete the application form. 

Please email the form and required documents to Lizette Pretorius at LPretorius@ufs.ac.za.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept